The largest database of trusted experimental protocols

Accolade 2

Manufactured by Stryker
Sourced in United States

The Accolade II is a lab equipment product manufactured by Stryker. It is a medical device designed for the analysis and processing of biological samples in a laboratory setting. The Accolade II provides fundamental functionality for essential laboratory tasks.

Automatically generated - may contain errors

13 protocols using accolade 2

1

Comparative Analysis of Cementless Femoral Stems

Check if the same lab product or an alternative is used in the 5 most similar protocols
After obtaining approval from our institutional review board (IRB #2021-060), 2 cementless femoral stem types with differing geometry from Stryker (Stryker Ltd., Kalamazoo, MI) were investigated: the Stryker Accolade II and the Stryker Secur-Fit Advanced (SFA) as seen in Figure 1. These 2 stem types were chosen to represent the most common tapered stem geometries typically used in THA: the single-wedge (Accolade II) and the dual-wedge (SFA) geometry [39 (link)].

(a) Stryker SFA implant representative of dual-wedge femoral stem geometry. (b) Stryker Accolade II implant representative of single-wedge femoral stem geometry.

+ Open protocol
+ Expand
2

Denosumab Effects on Periprosthetic Bone

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients underwent THA using a single-wedged, parallel-sided femoral stem (Accolade II, Stryker Orthopedics, Mahwah, NJ) with a 36-mm metallic head and a porous-coated uncemented acetabular cup with a polyethylene liner. Surgery was performed using an anterolateral Hardinge approach. The patients were mobilized using standard physiotherapy, and immediate unrestricted weight-bearing was encouraged with the aid of crutches. Patients were randomly assigned to receive antiresorptive denosumab treatment (a subcutaneous injection of 60 mg every 6 months) or placebo for 1 year, which started 4 weeks before surgery. As reported [ 8 Aro H. ], the denosumab-treated subjects showed increased periprosthetic BMD in clinically relevant regions of the proximal femur, but the treatment response was not associated with any reduction in the initial stem migration. No major surgical complications (dislocations, periprosthetic fractures, or infection) or drug-related adverse events were reported during the 1-year trial period and during a 3-year safety follow-up.
+ Open protocol
+ Expand
3

Uncemented THA with Trident and Optimys

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seventy-seven patients received an uncemented porous cup (Trident PSL cup; Stryker Orthopaedics, Mahwah, New Jersey, USA) with a highly crosslinked Trident X3 polyethylene liner (Stryker Orthopaedics). Twenty-three of the 77 patients with the Trident cups received uncemented, double-tapered, fully hydroxyapatite-coated femoral stems (Accolade II or Accolade I; Stryker Orthopaedics) with a V40 alumina ceramic head (Stryker Orthopaedics) and a 32-mm articulation. Fifty-four of the 77 patients with Trident cups received Optimys short-stem femoral implants (Mathys Ltd., Bettlach, Switzerland) with a Bionit2 alumina ceramic head (Mathys Ltd.) and a 32-mm articulation. The remaining 10 patients received a Kyosera Sqrum shell (Kyocera Medical Materials, Osaka, Japan) with an uncemented, double-tapered, fully hydroxyapatite-coated stem (Kyosera J Taper; Kyocera Medical Materials) and a 910 zirconia head (Kyocera Medical Materials) with a 32-mm articulation.
+ Open protocol
+ Expand
4

Cementless Total Hip Arthroplasty Technique

Check if the same lab product or an alternative is used in the 5 most similar protocols
All subjects underwent cementless total hip arthroplasty using an anterolateral Hardinge approach and implantation of a tapered, single-wedge femoral stem (Accolade II; Stryker) 23 , a 36-mm metallic head, and a cementless acetabular component with a polyethylene liner. The recommended broach-only technique 24 was employed to achieve adequate mediolateral cortical contact of the stem. Patients were mobilized postoperatively under the supervision of physiotherapists and unrestricted weight-bearing was allowed with the aid of crutches.
+ Open protocol
+ Expand
5

Dual Mobility Acetabular System Performance

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Anatomic Dual Mobility Restoration acetabular system (Stryker, Warsaw, Mazovia, Poland) with a mobile liner made of X3 highly cross-linked PE (Stryker, Warsaw, Mazovia, Poland) and a ceramic size 28-mm femoral head was used in both the phantom and the patient. The hip stems were a Bi-Metric size 7 (Biomet, Warsaw, IN, USA) in the phantom and Accolade II (Stryker, Warsaw, Mazovia, Poland) size 4 in the patient. Cup/liner 56-mm size was used in the phantom and 50-mm size was used in the patient. An experienced hip surgeon inserted the components into the Sawbone hip (No 1301-165-1, Sawbones, WA, USA) and also the patient by use of a posterolateral approach.
+ Open protocol
+ Expand
6

Cementless Total Hip Arthroplasty Radiographic Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cementless total hip arthroplasty was performed by a single orthopedic surgeon using an anterolateral Hardinge approach. The procedure involved implantation of a parallel‐sided femoral component11, 37 (Accolade II, Stryker Orthopaedics, Mahwah, NJ, USA), with a metallic head and a porous‐coated acetabular cup with polyethylene liner. The patients were mobilized with use of standard physiotherapy, and unrestricted weight‐bearing was encouraged with the aid of crutches.
A computerized method (Rhinoceros software, version 3.0SR5b, Robert McNeel & Associates, Seattle, WA, USA) was applied to measure femoral offset,38 canal flare index,39 cortical index,40 and stem‐to‐canal fill ratio41 from the anteroposterior hip radiographs. Fill ratio was defined as the percentage of endosteal space occupied by the implant.42 The ratio of the stem width over the femoral canal width was measured 10 mm above the lesser trochanter (proximal stem) and 60 mm below the lesser trochanter (middle stem).
+ Open protocol
+ Expand
7

Cementless Total Hip Arthroplasty with Accolade II Stem

Check if the same lab product or an alternative is used in the 5 most similar protocols
All subjects underwent standardized cementless THA with implantation of a tapered parallel‐sided single‐wedge femoral stem (Accolade II, Stryker Orthopedics, Mahwah, NJ, USA)(24) using the recommended broach‐only technique.(25) The stem is the most frequently used femoral component of cementless THA in the United States.(1) The investigated stem type requires adequate bone stock and unaltered femoral anatomy.(25) During surgery, multiple tantalum RSA beads (1 mm in diameter) were inserted into the trochanteric bone (Fig. 1). Patients were mobilized postoperatively under the supervision of physiotherapists, and unrestricted weight bearing was allowed with the aid of crutches.
+ Open protocol
+ Expand
8

Robotics-Assisted Total Hip Arthroplasty

Check if the same lab product or an alternative is used in the 5 most similar protocols
The enhanced workflow was used in all cases providing intra-operative feedback regarding broach and stem version, combined anteversion and guiding neck resection. Robotic arm assistance was used to perform reaming in the desired plane with the utilisation of stereotactic boundaries. The acetabular cup was also positioned with the assistance of the robotic arm and the haptic tunnel that maintains the planned orientation during implantation. In this prospective cohort study, all patients received a cementless femoral stem (Accolade II; Stryker, Mahwah, NJ, USA) and a peripheral self-locking porous acetabular shell (Trident PSL shell; Stryker).
+ Open protocol
+ Expand
9

Bilateral Direct Anterior Approach Total Hip Arthroplasty

Check if the same lab product or an alternative is used in the 5 most similar protocols
The consecutive patients who underwent bilateral DAA-THAs simultaneously between May 2016 and November 2018 in our institute were retrospectively reviewed. Inclusion criterion: 1. bilateral THAs were performed through DAA simultaneously; 2. bilateral THAs were completed by one surgeon with the cementless acetabular cup (Pinnacle, Depuy, New Jersey, USA) and tapered femoral stem (Accolade II, Stryker, Mahwah, USA); 3. bilateral hips had the same stage of the same etiology (Crowe classification and Ficat classification) and bilateral acetabulum had similar bone mass [10 (link), 11 (link)]; 4. neither hip had the deformity caused by previous surgery and trauma. Exclusion criterion: 1. periprosthetic joint infection (PJI) or periprosthetic fractures in the postoperative follow-up period; 2. the follow-up period was shorter than 1 year. A total of 115 patients met the inclusion criterion and 102 patients were enrolled in this study finally (Fig. 1). The surgeon in this study has performed about 500 cases of DAA-THA and been defined as right-hander by the Edinburgh Handedness Inventory [12 (link)]. Institutional Review Board approval for this study was obtained (S2019–029-01).

Flow chart of patient enrollment in this study

+ Open protocol
+ Expand
10

Direct Anterior Approach for Cementless Total Hip Arthroplasty

Check if the same lab product or an alternative is used in the 5 most similar protocols
All operations were performed via the direct anterior approach, with the patient in the supine position on a standard table with fluoroscopic control [19 (link)]. A cementless stem was used in all cases, including the Accolade TMZF or Accolade II (Stryker Orthopaedics, Mahwah, NJ, USA) in 153 hips, Taperloc Complete Microplasty system (Zimmer Biomet, Warsaw, IN, USA) in five, meta-diaphyseal anchoring calcar-guided short-stemmed Optimys (Mathys Ltd., Bettlach, Switzerland) in eight, TwinSys femoral stem (Mathys Ltd.) in two, and Modulus System (Lima Corporate San Daniele Del Friuli, Udine, Italy) in two. A cementless cup was used in 166 patients; the Trident cup (Stryker Orthopaedics) was used in 157 hips (modular dual mobility cup in 54 hips), G7 cup and G7 dual mobility system (Zimmer Biomet) were used in five, and a Kerboull-type acetabular reinforcement device with X3 Rim Fit (Stryker Orthopaedics) was used in four. Postoperatively, all patients followed the same rehabilitation protocol and walking exercise with full weight-bearing began on postoperative day 1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!